2024 HCPCS Code G0309
Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation
TAGS: pocket insertion different interstitial anatomic system removal subcutaneous implantable sensor glucose activation creation
| Notice | HCPCS G0309 terminated on December 31, 2022. |
| Short Description | Rem/inser glu sensor dif sit |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | January 01, 2023 |
| HCPCS Code Added Date | July 01, 2022 |
| HCPCS Pricing Indicator Code | 13 - Price established by carriers (e.G., not otherwise classified, individual determination, carrier discretion) |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- G9006 - Mccd, home monitoring
- G9007 - Mccd, sch team conf
- G9008 - Mccd,phys coor-care ovrsght
- G9009 - Mccd, risk adj, level 3
- G9010 - Mccd, risk adj, level 4
- G9011 - Mccd, risk adj, level 5
- G9012 - Other specified case mgmt
- G9013 - Esrd demo bundle level i
- G9014 - Esrd demo bundle-level ii
- G9016 - Demo-smoking cessation coun
- G9017 - Amantadine hcl 100mg oral
- G9018 - Zanamivir,inhalation pwd 10m
- G9019 - Oseltamivir phosphate 75mg
- G9020 - Rimantadine hcl 100mg oral
- G9033 - Amantadine hcl oral brand
- G9034 - Zanamivir, inh pwdr, brand
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand
- G9037 - Intrpro req fr rec phys/qhcp
- G9038 - Co-management services